David P. Snow
2019
In 2019, David P. Snow earned a total compensation of $1.9M as Chief Business Officer at Sevion Therapeutics, a 54% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $78,000 |
---|---|
Option Awards | $1,080,700 |
Salary | $388,750 |
Stock Awards | $288,250 |
Other | $48,505 |
Total | $1,884,205 |
Snow received $1.1M in option awards, accounting for 57% of the total pay in 2019.
Snow also received $78K in non-equity incentive plan, $388.8K in salary, $288.3K in stock awards and $48.5K in other compensation.
Rankings
In 2019, David P. Snow's compensation ranked 6,231st out of 13,971 executives tracked by ExecPay. In other words, Snow earned more than 55.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,231 | 55th |
Manufacturing | 2,339 | 59th |
Chemicals And Allied Products | 853 | 61st |
Drugs | 720 | 62nd |
Biological Products, Except Diagnostic Substances | 168 | 57th |
Snow's colleagues
We found three more compensation records of executives who worked with David P. Snow at Sevion Therapeutics in 2019.